May 2026
📣 VC round data is live. Check it out!
Largest Nutraceuticals & Cosmeceuticals Public Companies in India
Benchmark revenue and EBITDA valuation multiples for public comps like
Divi's Laboratories, Zydus Wellness, Procter & Gamble Health and Aarti Pharmalabs.
 | Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. It is engaged in the manufacture of Active Pharmaceutical ingredients (API), Intermediates, and Nutraceutical ingredients, with a predominance in exports. It also, through its custom synthesis, supports pharma companies for their patented products business from gram-scale requirements for clinical trials to launch, as well as late-life cycle management. Geographically, the company derives maximum revenue from Europe, and the rest from America, India, Asia (excluding India), and the Rest of the world. | $71 | -1% | $19B | $19B | 18.8x | 52.7x | ||
| Zydus Wellness Ltd is engaged in the production and distribution of health and wellness products. It has several brands, including Everyuth, Sugar-Free, and Nutralite. The company offers specialty skincare products under the brand Everyuth Naturals. Zydus's sugar-free product portfolio, a sugar substitute category, consists of Sugar-Free gold for tabletop usage and Sugar-Free Natura for culinary usage. The firm also offers healthy foods, including Nutralite, a healthy butter substitute. Company brands includes: Complan, Sugar Free, Glucon-D, Everyuth, Nycil, Nutralite, and Others. | $5 | -- | $2B | $2B | 7.2x | 48.4x | ||
| Procter & Gamble Health Ltd is an India based pharmaceutical company engaged in manufacturing and selling of healthcare products, viz., vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct & indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. Cosome, Evion, Neurobion, Nasivion, Polybion, Livogen and Seven Seas are some of the brands of the company. The geographical segments include sales in India and exports. | $57 | -9% | $941M | $909M | 9.4x | 26.1x | ||
| Aarti Pharmalabs Ltd manufactures pharmaceuticals and nutraceuticals with a footprint. The company manufactures Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, acids, and xanthine derivatives, including caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline in India. It also offers Contract Development and Manufacturing Services (CDMS) for drug substance (NCE, RSM, Intermediates) projects. Geographically, the company generates maximum revenue from its customers located outside India. | $8 | -18% | $736M | $800M | 3.6x | 15.9x | ||
| Median | $32 | -9% | $1B | $1B | 8.3x | 37.3x |
Financial data powered by FactSet and Morningstar. Valuation multiples as of current fiscal year. For more data, start your free trial here.
Recent Insights
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.